Funding-round

Fore Biotherapeutics - Series D Financing

CompanyFore Biotherapeutics
Amount$75,000,000
CurrencyUSD
Announcement date2023-08-25
Round typeSeries D Financing
Primary source urlhttps://www.finsmes.com/2023/08/fore-biotherapeutics-raises-75m-in-series-d-financing.html

Participating investors

CompanyLead
SR OneLead
MedicxiLead
OrbiMed
HBM Healthcare Investments
Novartis Venture Fund
3B Future Health Fund
Cormorant Asset Management
Wellington Management
Samsung Securities